Incheon, South Korea

Ji Young Shin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji Young Shin: Innovator in Influenza Virus Neutralization

Introduction

Ji Young Shin is a prominent inventor based in Incheon, South Korea. She has made significant contributions to the field of virology, particularly in the development of compositions aimed at neutralizing influenza A viruses. Her innovative work is crucial for advancing treatments and preventive measures against influenza.

Latest Patents

Ji Young Shin holds a patent for a composition comprising at least two influenza A virus-neutralizing binding molecules. This invention provides a method that includes a first binding molecule capable of neutralizing specific influenza A virus subtypes, such as H1, H2, H5, and H9. Additionally, it features a second binding molecule that targets other subtypes, including H3 and H7. The mixed composition effectively neutralizes multiple influenza subtypes from both phylogenetic groups, making it a valuable tool for preventing and treating influenza virus-related diseases. She has 1 patent to her name.

Career Highlights

Ji Young Shin is associated with Celltrion Inc., a leading biopharmaceutical company. Her work at Celltrion focuses on developing innovative solutions to combat viral infections, particularly influenza. Her research has the potential to impact public health significantly.

Collaborations

Ji Young Shin collaborates with notable colleagues, including Seung Suh Hong and Shin Jae Chang. These partnerships enhance the research and development efforts within her field, fostering innovation and progress.

Conclusion

Ji Young Shin's contributions to the field of virology, particularly through her patent on influenza virus-neutralizing compositions, highlight her role as an influential inventor. Her work at Celltrion Inc. and collaborations with esteemed colleagues further underscore her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…